Table 3.

Adverse outcomes of live birth fetuses

	pSS (n=128)	Controls (n=316)	Adjusted OR	95% CI	P value
Caesarean section*	94 (78.44%)	134 (42.41%)	3.627	(2.172 to 6.059)	<0.001
Premature birth*	17 (13.28%)	16 (5.06%)	2.227	(0.623 to 7.956)	0.218
Gestational age (day)†	240.07±17.80	240.31±17.23
Induced premature births	14 (10.94%)	11 (3.48%)
Underweight*	14 (10.94%)	13 (4.11%)	0.767	(0.160 to 3.676)	0.740
IUGR/SGA*	3 (2.34%)	4 (1.27%)	1.561	(0.152 to 16.031)	0.708
Postpartum intrauterine infection*	3 (2.34%)	2 (0.63%)	11.187	(1.025 to 122.123)	0.048
Postpartum haemorrhage*	5 (3.91%)	8 (2.53%)	0.780	(0.185 to 3.286)	0.735
Neonatal asphyxia*	3 (2.34%)	10 (3.16%)	0.243	(0.041 to 1.450)	0.121
Intrauterine distress*	16 (12.50%)	23 (7.28%)	1.225	(0.515 to 2.910)	0.646
Neonatal brain injury*	11 (8.59%)	19 (6.01%)	1.009	(0.327 to 3.114)	0.988
Superficial morphological malformation*	1 (0.79%)	2 (0.63%)	0.684	(0.048 to 9.746)	0.779
Cardiac abnormalities*	35 (27.34%)	38 (12.03%)	3.121	(1.333 to 7.307)	0.009
Elevated cardiac enzymes	25 (19.53%)	34 (10.76%)
Atrial/ ventricular septal defects	17 (13.28%)	5 (1.58%)
CHB	0 (0%)	0 (0%)
Pulmonary hypertension	1 (0.79%)	1 (0.32%)
Bovine aortic arch	1 (0.79%)	0 (0%)
Neonatal infection*	23 (17.97%)	31 (9.81%)	1.030	(0.420 to 2.527)	0.949
Neonatal acidosis*	2 (1.56%)	5 (1.58%)	0.535	(0.075 to 3.824)	0.533
Electrolyte disorder of newborn*	1 (0.79%)	2 (0.63%)	2.193	(0.103 to 46.684)	0.615
Neonatal jaundice*	14 (10.94%)	21 (6.65%)	1.330	(0.555 to 3.185)	0.522
Neonatal hospital admission*	45 (35.16%)	66 (20.89%)	1.132	(0.489 to 2.620)	0.772

Data were analysed by generalised linear regression method logistic.

*Number with the percentages between brackets.

†Mean±SD.

CHB, complete heart block; IUGR/SGA, intrauterine growth restriction/small for gestational age; n, number of deliveries.